Mirum Pharmaceuticals (MIRM) Treasury Shares (2018 - 2026)
Mirum Pharmaceuticals' (MIRM) quarterly Treasury Shares came in at $487498.0 in Q1 2026, up 37.81% year-on-year from $353743.0 in Q1 2025, and up 37.81% quarter-over-quarter from $353743.0 in Q4 2025.
Mirum Pharmaceuticals (MIRM) Treasury Shares (2018 - 2026) Analysis & Trends
Mirum Pharmaceuticals' Treasury Shares history runs 9 years deep, the most recent figure standing at $487498.0 for Q1 2026.
- On a quarterly basis, Treasury Shares rose 37.81% year-over-year to $487498.0 in Q1 2026; TTM through Mar 2026 was $487498.0, a 37.81% increase from a year earlier, with the FY2025 full-year figure at $353743.0, up 24.14% from the prior year.
- Treasury Shares improved to $487498.0 in Q1 2026 per MIRM's latest filing, from $353743.0 in the prior quarter.
- Across five years, Treasury Shares topped out at $487498.0 in Q1 2026 and bottomed at $22270.0 in Q3 2022.
- The 5-year median for Treasury Shares is $289862.5 (2024), against an average of $251279.2.
- Across the five-year window, Treasury Shares plunged 85.71% in 2022 and surged 120.92% in 2024, its largest moves.
- Year by year, Treasury Shares stood at $22270.0 in 2022, then soared by 563.83% to $147835.0 in 2023, then surged by 92.75% to $284955.0 in 2024, then grew by 24.14% to $353743.0 in 2025, then soared by 37.81% to $487498.0 in 2026.
- Per Business Quant, the three latest MIRM Treasury Shares figures stand at $487498.0 (Q1 2026), $353743.0 (Q4 2025), and $353743.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -21,709.08 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 265,401.92 |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 19.41 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 5.14 Mn |
| 10 | Mirum Pharmaceuticals | 6.73 Bn | 6.34 Bn | 131.08 Mn | 487,498.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 487,498.00 |
| Mar 31, 2026 | 487,498.00 |
| Dec 31, 2025 | 353,743.00 |
| Dec 31, 2025 | 353,743.00 |
| Sep 30, 2025 | 353,743.00 |
| Sep 30, 2025 | 353,743.00 |
| Jun 30, 2025 | 353,743.00 |
| Jun 30, 2025 | 353,743.00 |
| Mar 31, 2025 | 353,743.00 |
| Mar 31, 2025 | 353,743.00 |
| Dec 31, 2024 | 284,955.00 |
| Dec 31, 2024 | 284,955.00 |
| Sep 30, 2024 | 284,955.00 |
| Sep 30, 2024 | 284,955.00 |
| Jun 30, 2024 | 294,770.00 |
| Jun 30, 2024 | 294,770.00 |
| Mar 31, 2024 | 300,085.00 |
| Mar 31, 2024 | 300,085.00 |
| Dec 31, 2023 | 147,835.00 |
| Dec 31, 2023 | 147,835.00 |